Customize Your Learning Experience!

Mix-and-match sessions from these additional co-located conferences at no additional cost:

• Process & Product Validation
• Technology Transfer for Biopharmaceuticals
• Biopharmaceutical Raw Materials throughout the Product Lifecycle
• Viral Safety for Biologicals

Stay for the week so you can attend on Feb. 29 - March 2 for these conferences:

• Antibody Development & Production
• Recombinant Protein & Complex Biologic Development & Production
• Analytical Technologies for Biotherapeutic Development
• Biobetters & Biosimilars: Technologies & Development Strategies

Get the Most Out of Your Budget with the "All Access Pass" to Attend Sessions from All 9 Conferences

View the Agenda-At-A-Glance for the Entire Week.

Special Discounted Hotel Rate

Special Discounted Hotel Rate Available Until February 3, 2012.
To book your room, call 1-800-HILTONS and mention that you are an IBC attendee at this event.

Get Up To Date Event Information

Join our priority contact list and receive the latest event news.

IBC's Outsourcing Manufacturing of Biopharmaceuticals conference provides you insights into developing your risk-mitigation strategies and operational excellence that oversees supply chain security and raw material reliability, thereby delivering a successful agent-sponsor relationship and ensuring consistent high quality products from your CMO partners.

• Compliance audit and quality oversight – meeting the agency’s expectations
• Improving the manufacturing processes through partnership with CMOs
• Opportunities for co-development in cell therapies
• Leveraging simulation tools for optimal resource planning and capacity utilization
• Applying operational excellence and performance measurement to contract manufacturing
• Raw material evaluation and qualification: moving from development into commercial

Keynote Presentations

Biologics Product & Process Lifecycle Management: Genentech / Roche Experience
David Chang, Ph.D.
Senior Director, Global Biologics Manufacturing Science & Technology
Genentech, Inc., a member of the Roche group

Facility Fit Analysis – The First Step in a Long Journey
Greg Liposky, Ph.D.
Vice President & General Manager, Site Operations
MedImmune

Featured Presentation

Improving the Manufacturing Process Of CER-001, A Recombinant Human Apolipoprotein A-I HDL Mimetic
Jean-Louis Dasseux, Ph.D.
Chief Executive Officer
Cerenis Therapeutics

2012 Program Highlights include:

• Compliance Audit & Quality Oversight
• Co-Development with CMOs for Enhanced Technology or Innovation
• Modeling/Simulation Tools for Plant Optimization
• Ensuring Partnership Success During Technology Transfer
• Strategies for External Manufacturing and Measuring its KPI
• Supply Chain Risk Management
• Evaluation and Quality Management of Supplier-Derived Raw Materials

» View the agenda